the Government Gazette
THE Department of Health has finalised guidelines for assessing new medicines’ " value for money" in the local market, which is expected to help the government and medical schemes to determine which drugs to provide patients.
It will also open their decisions to greater public scrutiny, potentially giving more power to patient groups lobbying for access to expensive new medicines.
The guidelines, which were published in the Government Gazette on February 1 and come into effect on April 1, provide technical details of how pharmaceutical companies should build their arguments for the value-for-money of new treatments compared with the existing standard of care.
IN A politically damaging about-turn, the Health Professions Council of South Africa (HPCSA) has bowed to pressure from doctors and dentists and withdrawn its controversial tariff guidelines.
The guidelines were due to be published in the Government Gazette on Friday, and the HPCSA had hoped they would be used as a benchmark for the private healthcare sector. But the figures it published were slammed by the three most influential groups for healthcare professionals, which described them as unscientific and divorced from the costs of running a practice.